Singapore markets open in 4 hours 55 minutes
  • Straits Times Index

    3,271.57
    +23.81 (+0.73%)
     
  • S&P 500

    4,338.08
    -18.37 (-0.42%)
     
  • Dow

    34,081.82
    -215.91 (-0.63%)
     
  • Nasdaq

    13,504.27
    -35.03 (-0.26%)
     
  • BTC-USD

    37,313.31
    +275.63 (+0.74%)
     
  • CMC Crypto 200

    863.72
    +7.91 (+0.92%)
     
  • FTSE 100

    7,469.78
    +98.32 (+1.33%)
     
  • Gold

    1,819.10
    -33.40 (-1.80%)
     
  • Crude Oil

    87.08
    +1.48 (+1.73%)
     
  • 10-Yr Bond

    1.8460
    +0.0630 (+3.53%)
     
  • Nikkei

    27,011.33
    -120.01 (-0.44%)
     
  • Hang Seng

    24,289.90
    +46.29 (+0.19%)
     
  • FTSE Bursa Malaysia

    1,515.76
    +6.85 (+0.45%)
     
  • Jakarta Composite Index

    6,600.82
    +32.65 (+0.50%)
     
  • PSE Index

    7,253.61
    -34.60 (-0.47%)
     

Global Oral Transmucosal Drugs Marketplace 2021-2031 - Market Share Analysis of Leading Companies and YoY Growth Projections with Revenue Breakdown by Segment - ResearchAndMarkets.com

·4-min read

DUBLIN, December 09, 2021--(BUSINESS WIRE)--The "Oral Transmucosal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

This report on the global oral transmucosal drugs market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global oral transmucosal drugs market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. the report also provides the compound annual growth rate (CAGR) for the global oral transmucosal drugs market during the forecast period.

The report delves into the competitive landscape of the global oral transmucosal drugs market. Key players operating in the global oral transmucosal drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global oral transmucosal drugs market that have been profiled in this report.

Key Questions Answered

  • What are the major drivers, restraints, and opportunities in the market?

  • What will be the Y-o-Y growth of the global oral transmucosal drugs market between 2021 and 2031?

  • What are the revenue share projections of key segments of the global oral transmucosal drugs market during the forecast period?

  • Will North America continue to be the most profitable market for oral transmucosal drugs?

  • Which factors are anticipated to restrain the global oral transmucosal drugs market during the forecast period?

  • Which are the leading companies in the global oral transmucosal drugs market?

Key Topics Covered

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oral Transmucosal Drugs Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.4. Global Oral Transmucosal Drugs Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Key Mergers & Acquisitions

5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

5.3. Top 3 players operating in the market space

5.4. Clinical Trials & Pipeline Analysis

5.5. Oral Transmucosal Drugs Market SWOT Analysis

6. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Type, 2017-2031

6.4. Market Attractiveness Analysis, by Type

7. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Route of Penetration

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Route of Penetration, 2017-2031

7.4. Market Attractiveness Analysis, by Route of Penetration

8. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Distribution Channel, 2017-2031

8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Indication

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast, by Indication, 2017-2031

9.4. Market Attractiveness Analysis, by Indication

10. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Market Value Forecast, by Region

10.3. Market Attractiveness Analysis, by Country/Region

11. North America Oral Transmucosal Drugs Market Analysis and Forecast

12. Europe Oral Transmucosal Drugs Market Analysis and Forecast

13. Asia Pacific Oral Transmucosal Drugs Market Analysis and Forecast

14. Latin America Oral Transmucosal Drugs Market Analysis and Forecast

15. Middle East & Africa Oral Transmucosal Drugs Market Analysis and Forecast

16. Competition Landscape

16.1. Market Share Analysis, by Company, 2020

16.2. Company Profiles

16.2.1. LTS Lohmann Therapie-Systeme AG

16.2.2. Soligenix

16.2.3. ZIM Laboratories Limited

16.2.4. Access Pharmaceutical, Inc.

16.2.5. C.L Pharm

16.2.6. Seoul Pharmaceuticals

16.2.7. Cure Pharmaceutical

16.2.8. Aquestive Therapeutics, Inc.

16.2.9. Solvay S.A.

16.2.10. NAL Pharma

16.2.11. IntelGenx Corp.

16.2.12. Izun Pharmaceuticals

16.2.13. Eisai Co. Ltd.

16.2.14. AstraZeneca

16.2.15. Otsuka Pharmaceutical Co. Ltd.

16.2.16. Pfizer, Inc.

16.2.17. Teva Pharmaceutical Industries Ltd.

16.2.18. GlaxoSmithKline plc

16.2.19. Mylan N.V.

16.2.20. Bristol-Myers Squibb Company

For more information about this report visit https://www.researchandmarkets.com/r/o84lq9

View source version on businesswire.com: https://www.businesswire.com/news/home/20211209005524/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting